VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 8 filers reported holding VERTEX PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,874,496 | -51.1% | 16,800 | -56.4% | 0.01% | -50.0% |
| Q1 2024 | $16,093,385 | -37.6% | 38,500 | -39.3% | 0.01% | -41.2% |
| Q4 2023 | $25,796,826 | +79.6% | 63,400 | +53.5% | 0.02% | +30.8% |
| Q3 2023 | $14,361,662 | -6.8% | 41,300 | -5.7% | 0.01% | -7.1% |
| Q2 2023 | $15,413,658 | +3.6% | 43,800 | -7.2% | 0.01% | -17.6% |
| Q1 2023 | $14,871,304 | +28.4% | 47,200 | +17.7% | 0.02% | -5.6% |
| Q4 2022 | $11,580,078 | +77.7% | 40,100 | +78.2% | 0.02% | +125.0% |
| Q3 2022 | $6,515,000 | +113.4% | 22,500 | +92.3% | 0.01% | +166.7% |
| Q1 2022 | $3,053,000 | +29.9% | 11,700 | +9.3% | 0.00% | +50.0% |
| Q4 2021 | $2,350,000 | -2.5% | 10,700 | +4.9% | 0.00% | -33.3% |
| Q4 2020 | $2,411,000 | +196.9% | 10,200 | +108.2% | 0.00% | 0.0% |
| Q4 2018 | $812,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 55,400 | $12,130,000 | 0.08% |
| SIMPLEX TRADING, LLC | 668 | $14,625,000 | 0.03% |
| Maven Securities LTD | 1,000 | $217,000 | 0.02% |
| Allianz Asset Management GmbH | 53,700 | $11,758,000 | 0.01% |
| HBK INVESTMENTS L P | 4,700 | $1,029,000 | 0.01% |
| JPMORGAN CHASE & CO | 46,300 | $10,137,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |